<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230513058164N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-05-18</date_registration>
      <primary_sponsor>Yasouj University of Medical Sciences</primary_sponsor>
      <public_title>The comparative study of intravenous Ondansetron and Dexamethasone effects on reducing the incidence of postspinal anesthesia hypotension in elderly patients undergoing urologic surgeries</public_title>
      <acronym></acronym>
      <scientific_title>The comparative study of intravenous Ondansetron and Dexamethasone Effects on Reducing the Incidence of PostSpinal Anesthesia Hypotension in Elderly Patients Undergoing Urologic Surgeries</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-11-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/70087</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: 120 patients. are randomly assigned based on the inclusion and exclusion crietria, using  the software of the website http://www.Randomization.com . Their information are registered and informed consent obtained. Based on the central randomization system , the patient is  assigned to the study groups by contacting the randomization center . This is  done by a hospital colleague not involved in other stages of the study , Blinding description: .Patients are classified into three groups according to the randomization program and entered into the study according to the determined codes. In order to complete the study, the anesthesiologist assistant who is not participating in the study gives  i.v. injections  of Ondansetron or Dexamethasone in a 5 cc syringe preparation,  5 minutes prior to the spinal anesthesia. The patient, the caregivers of the operating room, the evaluator and the  data analyst.  are unaware of the type , dosage of drug injected.</study_design>
      <phase>3</phase>
      <hc_freetext>Condition 1: Post spinal hypotension  in elderly patients. Condition 2: Post Spinal Bradycardia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention Group A : Ondansetron Amp  4mg ,slow iv  , Single Dose، 5 minutes prior to Spinal Anesthesia. Intervention 2: Intervention Group B: Dexamethasone Amp  8mg  iv , Single Dose  , 5 minutes prior to Spinal Anesthesia,. Intervention 3: The control group consists of 40 patients who are randomly selected and receive a study participation code. They  receive  no injectable drug before spinal anesthesia.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Data recording sheets، Result Charts , Analytical Charts available in article link and research  text

When:
Available while article is accessible

To whom:
Research team

Conditions:
Upon formal request

Where to obtain:
Researcher

How to obtain:
Formal written request

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Masoumeh Tork</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Marzdaran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1463755184</zip>
        <telephone>+98 21 4424 7963</telephone>
        <email>aban253@gmail.com</email>
        <affiliation>Yasouj University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Masoumeh Tork</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Marzdaran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1463755184</zip>
        <telephone>+98 21 4424 7962</telephone>
        <email>aban253@gmail.com</email>
        <affiliation>Yasouj University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>65 years of age or more
American Society of Anesthesiologists (ASA) physical status
EF&gt;40%
Patients who do not have a contraindication for spinal anesthesia (such as coagulation disorder, thrombocytopenia )
Not allergic to local anesthetic No allergy to ondansetron or dexamethasone
Not taking drugs related to steroids or serotonin (for example, selective serotonin reuptake inhibitors)
Not suffering from uncontrolled cardiovascular, kidney, liver and thyroid diseases</inclusion_criteria>
      <agemin>65 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Study Confounding Items Such as: Occurrence of Surgical Complications Such as Bleeding
Hemodynamic Instability</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I95</hc_code>
      <hc_code>R00.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Hypotension</hc_keyword>
      <hc_keyword>Bradycardia, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention Group A : Ondansetron Amp  4mg ,slow iv  , Single Dose، 5 minutes prior to Spinal Anesthesia.</i_keyword>
      <i_keyword>Intervention Group B: Dexamethasone Amp  8mg  iv , Single Dose  , 5 minutes prior to Spinal Anesthesia,.</i_keyword>
      <i_keyword>The control group consists of 40 patients who are randomly selected and receive a study participation code. They  receive  no injectable drug before spinal anesthesia.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Systolic Blood Pressure. Timepoint: 5 minutes before and 30 minutes following Spinal Anesthesia . Method of measurement: Sphygmomanometer.</prim_outcome>
      <prim_outcome>Diastolic Blood Pressure. Timepoint: 5 minutes before and 30 minutes following Spinal Anesthesia. Method of measurement: Sphygmomanometer.</prim_outcome>
      <prim_outcome>Heart Rate. Timepoint: 5 minutes before and 30 minutes following Spinal Anesthesia  Procedure. Method of measurement: Pulse Oximeter.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Yasouj University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-10-26</approval_date>
        <contact_name>Yasuj University of Medical Sciences</contact_name>
        <contact_address>Shahid Motahhari Blvd Yasuj Kohgilouyeh-va-Boyrahmad Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
